Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ananth
S Parameswaran
S Gunatilake

Current pharmaceutical design

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|July 30, 2004
Side effects of atypical antipsychotic drugsJ Ananth, S Parameswaran, S Gunatilake
Current Pharmaceutical Design|July 30, 2004
Antipsychotic polypharmacyJ Ananth, S Parameswaran, S Gunatilake
Current Pharmaceutical Design|July 30, 2004
Rehabilitation of schizophrenic patientsS Gunatilake, J Ananth, S Parameswaran, et al.
Current Pharmaceutical Design|July 30, 2004
Drug therapy in schizophreniaJ Ananth, S Parameswaran, B Hara
Current Pharmaceutical Design|July 30, 2004
The use of antiparkinsonian agents in the management of drug-induced extrapyramidal symptomsK Burgyone, K Aduri, J Ananth, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|July 30, 2004
Side effects of atypical antipsychotic drugsJ Ananth, S Parameswaran, S Gunatilake
Current Pharmaceutical Design|July 30, 2004
Antipsychotic polypharmacyJ Ananth, S Parameswaran, S Gunatilake
Current Pharmaceutical Design|July 30, 2004
Rehabilitation of schizophrenic patientsS Gunatilake, J Ananth, S Parameswaran, et al.
Current Pharmaceutical Design|July 30, 2004
Drug therapy in schizophreniaJ Ananth, S Parameswaran, B Hara
Current Pharmaceutical Design|July 30, 2004
The use of antiparkinsonian agents in the management of drug-induced extrapyramidal symptomsK Burgyone, K Aduri, J Ananth, et al.
Pageof 1